Stock Track | GENSCRIPT BIO Soars 5.45% Intraday on Sector Optimism and Strong Associate Performance

Stock Track

May 13

GENSCRIPT BIO's stock surged 5.45% during intraday trading on Wednesday, reflecting significant investor interest in the biotechnology company.

The price movement appears to be driven by multiple positive factors. Eli Lilly's recent $7 billion acquisition of biotech firm Kelonia continues to boost sentiment across the entire cell therapy sector. Additionally, GenScript's associate company Legend Biotech reported robust first-quarter sales of approximately $597 million for its core product CARVYKTI, representing a substantial 61.8% year-over-year increase.

Analyst sentiment remains positive, with Morgan Stanley maintaining an "Overweight" rating and a HK$16.5 target price, while CICC maintains an "Outperform" rating with a HK$17.90 target price, both significantly above the current trading level.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1122365092"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122365092\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122365092?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 09:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122365092","market":"sg","top_or_hot":-1,"title":"Stock Track | GENSCRIPT BIO Soars 5.45% Intraday on Sector Optimism and Strong Associate Performance","media":"Stock Track","content":"<p>GENSCRIPT BIO's stock surged 5.45% during intraday trading on Wednesday, reflecting significant investor interest in the biotechnology company.</p><p>The price movement appears to be driven by multiple positive factors. Eli Lilly's recent $7 billion acquisition of biotech firm Kelonia continues to boost sentiment across the entire cell therapy sector. Additionally, GenScript's associate company Legend Biotech reported robust first-quarter sales of approximately $597 million for its core product CARVYKTI, representing a substantial 61.8% year-over-year increase.</p><p>Analyst sentiment remains positive, with Morgan Stanley maintaining an \"Overweight\" rating and a HK$16.5 target price, while CICC maintains an \"Outperform\" rating with a HK$17.90 target price, both significantly above the current trading level.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GENSCRIPT BIO Soars 5.45% Intraday on Sector Optimism and Strong Associate Performance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GENSCRIPT BIO Soars 5.45% Intraday on Sector Optimism and Strong Associate Performance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-13 09:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GENSCRIPT BIO's stock surged 5.45% during intraday trading on Wednesday, reflecting significant investor interest in the biotechnology company.</p><p>The price movement appears to be driven by multiple positive factors. Eli Lilly's recent $7 billion acquisition of biotech firm Kelonia continues to boost sentiment across the entire cell therapy sector. Additionally, GenScript's associate company Legend Biotech reported robust first-quarter sales of approximately $597 million for its core product CARVYKTI, representing a substantial 61.8% year-over-year increase.</p><p>Analyst sentiment remains positive, with Morgan Stanley maintaining an \"Overweight\" rating and a HK$16.5 target price, while CICC maintains an \"Outperform\" rating with a HK$17.90 target price, both significantly above the current trading level.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1122365092","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122365092","pubTimestamp":1778636349,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"GENSCRIPT BIO's stock surged 5.45% during intraday trading on Wednesday, reflecting significant investor interest in the biotechnology company.The price movement appears to be driven by multiple...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"个股追踪|金斯瑞生物盘中大涨5.45%板块乐观关联业绩强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"GENSCRIPT BIO's stock surged 5.45% during intraday trading on Wednesday, reflecting significant investor interest in the biotechnology company.The price movement appears to be driven by multiple positive factors. Eli Lilly's recent $7 billion acquisition of biotech firm Kelonia continues to boost sentiment across the entire cell therapy sector. Additionally, GenScript's associate company Legend Biotech reported robust first-quarter sales of approximately $597 million for its core product CARVYKTI, representing a substantial 61.8% year-over-year increase.Analyst sentiment remains positive, with Morgan Stanley maintaining an \"Overweight\" rating and a HK$16.5 target price, while CICC maintains an \"Outperform\" rating with a HK$17.90 target price, both significantly above the current trading level.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}